Today @ #USCAP2026: Faisal Mahmood, PhD, will highlight advances in computational pathology, from weakly supervised whole slide classification to multimodal foundation models, generative copilots, and emerging applications of AI in diagnostic workflows.
buff.ly/Ky5H0jU
Stop by the USCAP booth on the exhibit floor today for two excellent informal sessions:
USCAP Journals: Secrets of the Editorial Office | 12:30 – 1:00 PM
Serving the Membership: The Board’s Role | 1:30 – 2:00 PM
#USCAP2026
This afternoon at #USCAP2026 - join two of pathology’s most distinguished educators for interactive case-based sessions featuring diagnostic insights and practical lessons drawn from years of clinical experience.
Learn More ⬇️
Editors from USCAP’s journals will be sharing practical guidance on study design, structure, and positioning your work for publication later today from 4:30 PM - 6:00 PM in the Stars at Night Ballroom B1. Don't miss it! #USCAP2026
Learn More ⬇️
buff.ly/lYYHOqB
Share lunch and conversation with leaders in pathology during today's Mentors at the Table lunch! Designed especially for residents and fellows. Seats are first come first serve!
Monday, March 23, 2026 | 12:00 – 1:00 PM | Stars at Night Terrace
Learn More ➡️ my.uscap.org/app/program/...
The exhibit hall is now open at #USCAP2026! Swing by the USCAP Membership booth and enjoy a rest in our comfortable lounge (conveniently located right by the coffee station) or make a bracelet and some new friends at our craft table 😄
Today's Fellowship Fair is open to all #USCAP2026 attendees interested in exploring future training pathways!
Meet representatives from fellowship programs and learn more about training opportunities across a wide range of pathology subspecialties.
Learn More ➡️ buff.ly/j3mL6uV
Today, our companion societies are leading specialized sessions across a wide range of pathology topics.
View the full list of societies meeting today at #USCAP2026! ⬇️
buff.ly/bt5Ufso
Reconnect with colleagues and meet new members of the pathology community at #USCAP2026's Gathering at the Grotto! Immediately following the Maude Abbott Lecture. We can't wait to see you there 🥳
➡️ buff.ly/tPlHdlr
Coming up soon at #USCAP2026 - The Maude Abbott Lecture featuring Dr. John R. Goldblum, MD!
This year’s lecture reflects on mentorship, professional relationships, and the experiences that shape a career in academic surgical pathology. Don't miss it!
New to the USCAP Annual Meeting? Our first timers session offers an overview of the meeting and helpful tips for navigating the program and making the most of your time in San Antonio!
#USCAP2026
➡️ buff.ly/qudE6ez
The big day is almost here! #USCAP2026 starts tomorrow and we're so excited for our pathology community to be joining us here in San Antonio.
Make sure you tag your posts with #USCAP2026 to share your excitement and discoveries with other attendees.
Ready to share your excitement for #USCAP2026?
We’ve put together graphics and banners you can use to let colleagues know you’ll be attending, presenting a poster, or speaking in San Antonio.
Learn more:
Loss of Methylthioadenosine Phosphorylase (MTAP) Expression: A Potentially Useful Tool for Distinguishing Sarcomatoid Urothelial Carcinoma from Inflammatory Myofibroblastic Tumor
✅ Just Accepted
📗 @modernpathology.bsky.social
#pathology #PathSky #MedSky
We're nearly one week out from #USCAP2026 and excited to reconnect with the pathology community in San Antonio. It’s not too late to register for in-person or on-demand access. Don’t miss the learning and community that make the Annual Meeting special 🤠
2026am.uscap.org
#MedSky #PathSky
Clinical Utility of Next-Generation Sequencing in Tumors Diagnosed as Lung Squamous Cell Carcinoma: Real-World Data of Diagnostic and Therapeutic Implications
✅ Just Accepted
📗 @modernpathology.bsky.social
#pathology #PathSky #MedSky
High-resolution Spatial Transcriptomic Characterization of Syncytial Variant of Nodular Sclerosis Classical Hodgkin Lymphoma
✅ Just Accepted
📘 @labinvest.bsky.social
#pathology #PathSky #MedSky
⏳ Only 17 days until #USCAP2026! What are you most excited for this year?
🔬 New research
🤝 Connecting with colleagues
📚 Learning from experts
🌎 Being part of the global pathology community
#pathology #PathSky #MedSky
Know a trainee or early career colleague attending? Tag them below so they don’t miss what’s waiting for them in San Antonio! 🤠
We are beyond excited to welcome Pathologists-in-Training to #USCAP26. To help you get started, we’ve put together a handy guide highlighting sessions and events tailored specifically for residents and fellows.
#pathology #PathSky #MedSky
The Complexity and Challenges of Translating the Dark Zone Signature into Immunohistochemistry in Diffuse Large B-Cell Lymphoma
✅ Just Accepted
📗 @modernpathology.bsky.social
#pathology #PathSky #MedSky
Dual-Stream Deep Feature and Cell Phenotype Fusion Model for the Diagnosis of Myeloproliferative Neoplasms
✅ Just Accepted
📘 @labinvest.bsky.social
#pathology #PathSky #MedSky
Emerging Molecular Defined Bone and Soft Tissue Diagnoses: When Do They Matter?
✅ Just Accepted
📗 @modernpathology.bsky.social
#pathology #PathSky #MedSky
We’re less than a month away from USCAP’s Annual Meeting in San Antonio! The premier event in pathology is almost here, and we’re excited to see our community come together once again.
Will we see you there? 🤠
#USCAP26 #PathSky #MedSky
Our field advances because experienced pathologists take the time to guide those coming up behind them.
Apply to serve as a mentor in the USCAP Mentoring Academy and invest in the future of our profession.
Register now for Evaluation of Low Levels of HER2 Expression in Breast Cancer: A Case-Based Approach
February 25, 2026 at 11:00 AM PST
elearning.uscap.org/courses/1235...
Discussion (cont): The key molecular hallmark of secretory carcinoma is the presence of a recurrent chromosome rearrangement, generating ETV6-NTRK3 Fusion. Immunohistochemistry for pan-Trk is positive in this case, a sensitive and specific surrogate for NTRK rearrangement.
Discussion (cont): Intracytoplasmic vacuoles and eosinophilic secretory material in luminal spaces are characteristic for this subtype. The tumor cells are negative for ER, PR and HER2.
Discussion: The tumor forms a well-circumscribed mass. The tumor cells are small to medium-sized, round to oval in shape with eosinophilic cytoplasm and low mitotic rate.
